Florian Heitz, Lyndsay Willmott, Hanne From Mathiesen, Lucy Gilbert, Alberto Mendivil, Laura Zavallone, Ashley Stuckey, Zoltán Novák, John Paul Diaz, Annemarie Thijs, Michael Teneriello, Mitchell Edelson, Robert W. Holloway, Amy J. Armstrong, Barbara Buttin, Matthew A. Powell, Bernd Westermayer, Qin Shen, Mansoor Raza Mirza, Kari Ring. "Time to quality of life (QoL) improvement or deterioration in patients (pts) with primary advanced or recurrent endometrial cancer (pA/R EC) treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5600